Steroids for Post-Tonsillectomy Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a single dose of the steroid dexamethasone (also known as Decadron, Dexone, or Hexadrol) can reduce pain after a tonsillectomy, potentially decreasing the need for narcotic pain medications. Participants will receive either the steroid or a placebo (a harmless pill with no active drug) three days after their surgery. The trial is suitable for children aged 3-12 who have undergone a tonsillectomy and returned home the same day. As a Phase 2 trial, the research measures the treatment's effectiveness in an initial, smaller group of participants.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you have used steroids for more than three days or any opioids in the 30 days before the tonsillectomy.
Is there any evidence suggesting that this treatment is likely to be safe for humans?
Research has shown that dexamethasone is usually well-tolerated for post-surgery pain. In studies, patients taking dexamethasone reported less pain, nausea, and vomiting, along with better healing and fewer complications. Importantly, these patients did not experience significant side effects.
However, one study found a higher risk of bleeding with a single dose of dexamethasone during surgery, though other studies did not observe this. In children, dexamethasone reduced early pain and nausea without increasing the risk of post-surgery bleeding.
Overall, dexamethasone appears to be a safe and effective option for managing pain after a tonsillectomy.12345Why do researchers think this study treatment might be promising for post-tonsillectomy pain?
Most treatments for post-tonsillectomy pain involve standard pain relievers like acetaminophen or ibuprofen, which manage discomfort but don't specifically address inflammation that can exacerbate pain. Dexamethasone is unique because it is a steroid that targets inflammation directly, potentially reducing pain more effectively. Researchers are excited about dexamethasone because it is given as a one-time oral dose, which could simplify pain management and enhance recovery on the crucial third post-operative day. This approach might offer faster relief and improved comfort compared to traditional painkillers, making the recovery process smoother for patients.
What evidence suggests that dexamethasone might be an effective treatment for post-tonsillectomy pain?
Research shows that dexamethasone can help reduce pain after tonsil removal. In this trial, participants in the Steroid Group will receive a single dose of dexamethasone, which has lowered pain by about 23% within four hours in previous studies. Those who took dexamethasone also experienced less pain on the third day after surgery. Besides easing pain, dexamethasone alleviated nausea, vomiting, and aided overall recovery, with no reported side effects. Overall, dexamethasone appears promising for managing symptoms after tonsil surgery and may reduce the need for stronger pain medications.12367
Who Is on the Research Team?
Phayvanh Pecha, MD
Principal Investigator
Medical University of South Carolina
Are You a Good Fit for This Trial?
This trial is for children aged 3-12 undergoing outpatient tonsillectomy, with or without adenoidectomy. It's not suitable for kids with bleeding disorders, recent steroid or opioid use, surgical complications, or if the guardian cannot be reached by phone.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery and Initial Recovery
Participants undergo tonsillectomy and initial recovery, including randomization to receive either a steroid or placebo on the third post-operative day
Post-operative Monitoring
Participants' pain and medication use are monitored daily for 6 days post-surgery using a diary
Follow-up
Participants are monitored for complications such as oropharyngeal hemorrhage, emergency room visits, and readmissions within 30 days post-surgery
What Are the Treatments Tested in This Trial?
Interventions
- Dexamethasone
Dexamethasone is already approved in European Union, United States, Canada, Japan for the following indications:
- Inflammation
- Allergic reactions
- Respiratory diseases
- Skin conditions
- Eye diseases
- Immune system disorders
- Inflammatory conditions
- Allergic states
- Respiratory diseases
- Blood disorders
- Neoplastic diseases
- Nervous system disorders
- Inflammation
- Allergic reactions
- Respiratory diseases
- Skin conditions
- Eye diseases
- Inflammatory conditions
- Allergic states
- Respiratory diseases
- Blood disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor